| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.571.144 | 10.756.184 | 13.107.020 | 17.838.995 | 21.389.217 | 26.485.854 | 26.570.610 | 31.268.292 | 33.711.307 | 36.755.355 |
| Total Income - EUR | 6.857.113 | 11.072.343 | 14.097.201 | 18.058.561 | 21.558.696 | 26.715.146 | 26.756.745 | 31.524.464 | 34.440.290 | 37.369.156 |
| Total Expenses - EUR | 6.724.090 | 10.519.119 | 13.471.370 | 17.548.859 | 21.104.247 | 25.781.437 | 25.837.882 | 30.922.948 | 33.511.124 | 36.831.939 |
| Gross Profit/Loss - EUR | 133.023 | 553.224 | 625.831 | 509.702 | 454.448 | 933.708 | 918.863 | 601.517 | 929.166 | 537.217 |
| Net Profit/Loss - EUR | 111.949 | 472.991 | 505.448 | 438.407 | 397.604 | 817.104 | 811.409 | 522.063 | 873.357 | 500.815 |
| Employees | 29 | 54 | 79 | 95 | 96 | 94 | 93 | 91 | 90 | 94 |
Check the financial reports for the company - Pharm Ahead S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 458.465 | 476.341 | 521.358 | 398.568 | 883.680 | 812.197 | 3.077.443 | 6.322.964 | 6.276.412 | 6.232.810 |
| Current Assets | 4.594.229 | 5.053.433 | 6.359.500 | 8.004.153 | 9.968.335 | 11.242.502 | 12.655.784 | 13.184.008 | 12.178.482 | 13.000.997 |
| Inventories | 1.285.897 | 1.726.675 | 2.528.060 | 3.549.570 | 5.355.842 | 5.087.746 | 4.809.720 | 5.208.867 | 7.025.581 | 7.625.387 |
| Receivables | 3.054.764 | 2.966.715 | 3.445.449 | 3.849.663 | 4.344.232 | 5.050.890 | 6.445.887 | 6.797.607 | 4.430.585 | 4.819.820 |
| Cash | 253.569 | 360.043 | 385.992 | 604.920 | 268.261 | 1.103.867 | 1.400.177 | 1.177.533 | 722.317 | 555.789 |
| Shareholders Funds | 945.762 | 473.258 | 970.829 | 1.391.420 | 1.762.077 | 2.339.041 | 3.098.579 | 3.326.089 | 4.189.360 | 4.465.729 |
| Social Capital | 225 | 223 | 218.909 | 214.892 | 210.730 | 620.206 | 606.453 | 1.013.890 | 1.010.816 | 1.005.167 |
| Debts | 4.106.873 | 5.070.455 | 5.925.416 | 7.025.148 | 9.100.705 | 9.725.704 | 12.644.376 | 16.198.889 | 14.400.226 | 14.907.197 |
| Income in Advance | 6.113 | 3.110 | 0 | 0 | 0 | 0 | 1.782 | 1.331 | 9.695 | 12.411 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Pharm Ahead S.r.l.